The importance of the tight regulation of these receptors and in particular Her2 is signified in human breast cancers, where Her2 is overexpressed by approximately 20 to 30% and this is normally associated with more aggressive tumours and a poorer prognosis [7,8]. This evidence concerns the gene ERBB2 and breast cancer.